Discontinuation report GD-VENLAFAXINE XR
Report ID | 45713 |
Drug Identification Number | 02360047 |
Brand name | GD-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 90's |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-06-12 |
Remaining supply date | 2018-06-12 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-06-14 | French | Compare |
v7 | 2018-06-14 | English | Compare |
v6 | 2018-06-14 | French | Compare |
v5 | 2018-06-14 | English | Compare |
v4 | 2018-06-14 | French | Compare |
v3 | 2018-06-14 | English | Compare |
v2 | 2018-04-13 | French | Compare |
v1 | 2018-04-13 | English | Compare |
Showing 1 to 8 of 8